Skip to main content

Series C Biopharma Companies

Explore 25 biopharma startups that raised series c funding. Access verified founder contact information and fundraising data.

Total Companies
25
Total Funding
$1.7B
Avg Funding
$66.3M
Cities
19

Export 25 Series C Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Ann Arbor, United States
$123.0M
raised

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

Sep 2026
Series C

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$300.0M
raised

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Sep 2022
Series C

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$120.0M
raised

AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.

Aug 2026
Series C

Founder Contacts

41,000+ verified contacts

Tokyo, Japan
$7.3M
raised

Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

Aug 2021
Series C

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$7.0M
raised

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

Jul 2022
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 25 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$70.0M
raised

Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Jul 2026
Series C

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Jun 2024
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$150.0M
raised

ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.

Mar 2022
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$73.9M
raised

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Mar 2025
Series C

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Mar 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 25 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Woburn, United States
$39.6M
raised

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Seattle, United States
$30.0M
raised

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

New York, United States
$44.0M
raised

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Aug 2025
Series C

Founder Contacts

41,000+ verified contacts

Lyon, France
$6.9M
raised

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Jun 2025
Series C

Founder Contacts

41,000+ verified contacts

Wadenswil, Switzerland
$54.9M
raised

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 25 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fujisawa, Japan
$10.2M
raised

Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.

Jan 2024
Series C

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$44.6M
raised

Genomics plc aiming to lead the genomic transformation of healthcare.

Jan 2024
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$33.5M
raised

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

Jan 2024
Series C

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$92.0M
raised

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Seattle, United States
$100.0M
raised

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Jan 2025
Series C

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 25 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$100.0M
raised

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Nov 2021
Series C

Founder Contacts

41,000+ verified contacts

Montreal, Canada
$53.0M
raised

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

Nov 2024
Series C

Founder Contacts

41,000+ verified contacts

Culver City, United States
$96.0M
raised

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Boston, United States
$12.0M
raised

Animol Discovery is a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Oct 2025
Series C

Founder Contacts

41,000+ verified contacts

Montréal, Canada
$69.3M
raised

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

Oct 2022
Series C

Founder Contacts

41,000+ verified contacts

Ready to Connect with Series C Biopharma Startups?

Get verified founder emails, funding details, and company data for 25 series c biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked